151 related articles for article (PubMed ID: 7877822)
1. The aging substantia nigra: quantitative histologic study.
Faraldi F; Reyes MG; Alfieri E; Levi AC
Panminerva Med; 1994 Sep; 36(3):103-8. PubMed ID: 7877822
[TBL] [Abstract][Full Text] [Related]
2. Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.
Beach TG; Sue LI; Walker DG; Lue LF; Connor DJ; Caviness JN; Sabbagh MN; Adler CH
Acta Neuropathol; 2007 Oct; 114(4):419-24. PubMed ID: 17639428
[TBL] [Abstract][Full Text] [Related]
3. Histopathology of the substantia nigra in Alzheimer's disease.
Reyes MG; Faraldi F; Chandran R; Verano A; Levi AC
Panminerva Med; 1996 Mar; 38(1):8-14. PubMed ID: 8766873
[TBL] [Abstract][Full Text] [Related]
4. Decreased nigral neuromelanin in Alzheimer's disease.
Reyes MG; Faraldi F; Rydman R; Wang CC
Neurol Res; 2003 Mar; 25(2):179-82. PubMed ID: 12635519
[TBL] [Abstract][Full Text] [Related]
5. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
6. Dolichol is the major lipid component of human substantia nigra neuromelanin.
Fedorow H; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B
J Neurochem; 2005 Feb; 92(4):990-5. PubMed ID: 15686500
[TBL] [Abstract][Full Text] [Related]
7. A quantitative investigation of the substantia nigra in Huntington's disease.
Oyanagi K; Takeda S; Takahashi H; Ohama E; Ikuta F
Ann Neurol; 1989 Jul; 26(1):13-9. PubMed ID: 2528318
[TBL] [Abstract][Full Text] [Related]
8. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
Zecca L; Casella L; Albertini A; Bellei C; Zucca FA; Engelen M; Zadlo A; Szewczyk G; Zareba M; Sarna T
J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
10. Substantia nigra degeneration in motor neurone disease: a quantitative study.
Burrow JN; Blumbergs PC
Aust N Z J Med; 1992 Oct; 22(5):469-72. PubMed ID: 1445037
[TBL] [Abstract][Full Text] [Related]
11. Evidence for specific phases in the development of human neuromelanin.
Fedorow H; Halliday GM; Rickert CH; Gerlach M; Riederer P; Double KL
Neurobiol Aging; 2006 Mar; 27(3):506-12. PubMed ID: 15916835
[TBL] [Abstract][Full Text] [Related]
12. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
Zecca L; Tampellini D; Gerlach M; Riederer P; Fariello RG; Sulzer D
Mol Pathol; 2001 Dec; 54(6):414-8. PubMed ID: 11724917
[TBL] [Abstract][Full Text] [Related]
14. Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.
Plum S; Helling S; Theiss C; Leite REP; May C; Jacob-Filho W; Eisenacher M; Kuhlmann K; Meyer HE; Riederer P; Grinberg LT; Gerlach M; Marcus K
J Proteomics; 2013 Dec; 94():202-206. PubMed ID: 23917253
[TBL] [Abstract][Full Text] [Related]
15. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
[TBL] [Abstract][Full Text] [Related]
16. Preliminary observations on the neuromelanic pigment in the substantia nigra nucleus of the cat.
Levi AC; De Mattei M; Graziano E
Boll Soc Ital Biol Sper; 1982 Feb; 58(3-4):165-8. PubMed ID: 7066112
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
18. Total and paramagnetic metals in human substantia nigra and its neuromelanin.
Zecca L; Swartz HM
J Neural Transm Park Dis Dement Sect; 1993; 5(3):203-13. PubMed ID: 8396395
[TBL] [Abstract][Full Text] [Related]
19. Substantia nigra tangles are related to gait impairment in older persons.
Schneider JA; Li JL; Li Y; Wilson RS; Kordower JH; Bennett DA
Ann Neurol; 2006 Jan; 59(1):166-73. PubMed ID: 16374822
[TBL] [Abstract][Full Text] [Related]
20. Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging.
Korzhevskii DE; Kirik OV; Guselnikova VV; Tsyba DL; Fedorova EA; Grigorev IP
Eur J Histochem; 2021 Sep; 65(s1):. PubMed ID: 34468106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
